Biogen BIIB
NASDAQ BIIB
$253.40 +2.92 (+1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Biogen (BIIB) Gains (Losses) on Sale of Assets & Investments (2012 - 2024)

Updated

Biogen's Gains (Losses) on Sale of Assets & Investments was $88.6 million in FY2024.

Analysis

Biogen (BIIB) Gains (Losses) on Sale of Assets & Investments (2012 - 2024) Analysis & Trends

  • The FY2024 figure marks the lowest annual Gains (Losses) on Sale of Assets & Investments since FY2010.
  • Per Business Quant data, Gains (Losses) on Sale of Assets & Investments in earlier years was $503.7 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Biogen 37.46 Bn 26.77 Bn 2.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 88.60 Mn
Dec 31, 2014 4.66 Mn
Sep 30, 2014 4.38 Mn
Jun 30, 2014 3.90 Mn
Mar 31, 2014 3.86 Mn
Dec 31, 2013 7.58 Mn
Sep 30, 2013 6.95 Mn
Jun 30, 2013 5.32 Mn
Mar 31, 2013 5.05 Mn
Dec 31, 2012 15.07 Mn
Sep 30, 2012 31.72 Mn
API Access

Biogen Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=BIIB&period=max&api_key=YOUR_API_KEY